Topics

Carboplatin-Pemetrexed Effective for Elderly Patients With Non-small Cell Lung Cancer

13:58 EDT 25 Mar 2020 | Medscape

Carboplatin plus pemetrexed followed by maintenance pemetrexed is an effective alternative to docetaxel monotherapy for elderly patients with advanced nonsquamous non-small cell lung cancer (NSCLC), researchers in Japan report.
Reuters Health Information

Original Article: Carboplatin-Pemetrexed Effective for Elderly Patients With Non-small Cell Lung Cancer

NEXT ARTICLE

More From BioPortfolio on "Carboplatin-Pemetrexed Effective for Elderly Patients With Non-small Cell Lung Cancer"

Quick Search

Relevant Topic

Gilotrif (afatinib)
GILOTRIF (afatinib) is a kinase inhibitor indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L8...